Sign In
Buy HROW
$33.32
+0.460 (+1.40%)
At Close: Jun 03, 2026
Harrow Health (HROW) Reports Q2 Loss, Tops Revenue Estimates
06:33pm, Tuesday, 10'th Aug 2021
Harrow (HROW) delivered earnings and revenue surprises of 15.38% and 16.02%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Harrow Health: Q2 Earnings Insights
04:38pm, Tuesday, 10'th Aug 2021
Shares of Harrow Health (NASDAQ:HROW) were flat after the company reported Q2 results. Quarterly Results Earnings per share decreased 1000.00% year over year to ($0.11), which missed the estimate of
Is Harrow Health (HROW) Stock Outpacing Its Medical Peers This Year?
12:55pm, Wednesday, 28'th Jul 2021
Is (HROW) Outperforming Other Medical Stocks This Year?
Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021
09:00am, Monday, 26'th Jul 2021
NASHVILLE, Tenn., July 26, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the sec
Down 14% in 4 Weeks, Here's Why You Should You Buy the Dip in Harrow (HROW)
11:41am, Friday, 16'th Jul 2021
The heavy selling pressure might have exhausted for Harrow (HROW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in
Bet on 4 Low-Beta MedTech Stocks to Ride the Choppy Market
09:01am, Tuesday, 06'th Jul 2021
Stocks like Henry Schein (HSIC), BellRing Brands (BRBR), Harrow Health (HROW) and West Pharmaceuticals Services (WST) are solid low-beta picks with strong fundamentals.
Yes, You Can Retire On Dividends
08:35am, Wednesday, 23'rd Jun 2021
Dividends can fund a wonderful retirement.
Harrow (HROW) Surges 12%: Is This an Indication of Further Gains?
07:31am, Wednesday, 23'rd Jun 2021
Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
04:01pm, Thursday, 17'th Jun 2021
NASHVILLE, Tenn., June 17, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the closing
Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
05:59pm, Monday, 14'th Jun 2021
NASHVILLE, Tenn., June 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the pricing
Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones
07:45am, Monday, 14'th Jun 2021
NASHVILLE, Tenn., June 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced that it has
Harrow Health: Return On Capital Employed Insights
09:54am, Wednesday, 02'nd Jun 2021
Harrow Health (NASDAQ:HROW) posted a 7.77% decrease in earnings from Q4. Sales, however, increased by 5.81% over the previous quarter to $15.44 million.
Harrow Health: An 8.3% Baby Bond Yield With Low Balance Sheet Leverage
06:44am, Friday, 28'th May 2021
Harrow Health: An 8.3% Baby Bond Yield With Low Balance Sheet Leverage
Harrow Health, Inc. (HROW) CEO Mark Baum on Q1 2021 Results - Earnings Call Transcript
06:28pm, Tuesday, 11'th May 2021
Harrow Health, Inc. (HROW) CEO Mark Baum on Q1 2021 Results - Earnings Call Transcript
Recap: Harrow Health Q1 Earnings
04:18pm, Tuesday, 11'th May 2021
Shares of Harrow Health (NASDAQ:HROW) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 102.00% year over year to $0.01, which bea
